Last $110.90 USD
Change Today +0.82 / 0.74%
Volume 198.7K
TFX On Other Exchanges
New York
As of 8:04 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

550 East Swedesford Road

Suite 400

Wayne, PA 19087

United States



Teleflex Incorporated provides medical technology products. The company primarily designs, develops, manufactures, and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers in approximately 150 countries through a combination of its direct sales force and distributors. The company manufactures its products at 27 manufacturing sites, with major manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. Critical Care The company is a provider of specialty products for critical care, which is predominantly comprised of single-use products. The company’s critical care products are used in a range of procedures for vascular access, anesthesia and airway management, respiratory therapy, treatment of urologic conditions and other specialty procedures. The majority of its critical care products are sold to the hospitals and healthcare providers, with a smaller percentage sold to alternate sites, such as home care, emergency medical services (EMS), long term care centers, primary care centers, hospice and animal health facilities. Vascular Access The company’s vascular access products facilitate various critical care therapies, including the administration of intravenous medications and other therapies and the measurement of blood pressure and taking of blood samples through a single puncture site. The company’s vascular access catheters and related devices consist principally of the following: ARROW central venous catheters, or CVCs, are inserted in the neck or shoulder area, come in multiple lengths and up to four channels, or lumens. The ARROW CVC has a pressure injectable option which gives clinicians who perform contrast-enhanced CT scans the ability to use an indwelling pressure injectable ARROW CVC to inject contrast dye for their scan without having to insert a second catheter. ARROW arterial catheterization sets facilitate arterial pressure monitoring and blood withdrawal for glucose, blood-gas and electrolyte measurement in a variety of critical care and intensive care settings. ARROW peripherally inserted central catheters, or PICCs, are soft, flexible catheters that are inserted in the upper arm and advanced into the superior vena cava to administer various types of intravenous medications and therapies. ARROW PICCs have a pressure injectable option that can withstand the higher pressures required by the injection of contrast media for CT scans. ARROW percutaneous sheath introducers are used to insert cardiovascular and other catheterization devices into the vascular system during critical care procedures. ARROW jugular axillo-subclavian central catheters, or JACC, with Chlorag+ard technology provide an alternative to traditional acute CVCs and peripheral central venous access. Introduced in 2013, this CVC for acute or long-term use combines antimicrobial and antithrombogenic protection with smaller french sizes to meet the challenges posed by patients. This product is used for patients with renal issues, chronic patients with poor peripheral access or those with a history of or risk for venous thrombosis. The ARROW VPS is an advanced vascular positioning system that facilitates precise placement of a PICC or CVC within the heart. The ARROW VPS analyzes multiple metrics, in real time, from its biosensor to help clinicians navigate through the vasculature and identify the correct catheter tip placement in the heart. In 2013, the company launched its ARROW VPS, the ARROW VPS G4, which provides further enhancements to its VPS technology, such as statement of final catheter position, improved sterile field capability and integration with hospital data management systems. The Vidacare EZ-IO system, added to its vascular product portfolio through its acquisition of Vidacare Corporation in December 2013, provides immediate vascular access for the delivery of medications and fluids via the intraosseous route, or in the bone, when traditional vascular


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TFX:US $110.90 USD +0.82

TFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ansell Ltd A$19.55 AUD +0.26
Hill-Rom Holdings Inc $43.62 USD +0.04
PerkinElmer Inc $41.72 USD +0.59
Sirona Dental Systems Inc $78.54 USD +0.38
STERIS Corp $59.60 USD -0.75
View Industry Companies

Industry Analysis


Industry Average

Valuation TFX Industry Range
Price/Earnings 30.5x
Price/Sales 2.6x
Price/Book 2.3x
Price/Cash Flow 28.1x
TEV/Sales 1.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TELEFLEX INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at